Table 2.
Periprocedural Characteristics
| Procedure, n (%) | |
| PVAC | 22 (73) |
| PVAC/MASC/MAAC | 8 (27) |
| Device | |
| Number | 1.5 (1–2) |
| Size, mm | 24 (24–24) |
| Size, n (%) | |
| 21 | 5 (17) |
| 24 | 18 (60) |
| 27 | 6 (20) |
| 30 | 1 (3) |
| Total procedure time, min | 97.3 (75–115) |
| LAA closure, min | 38 (30–51) |
| Total fluoroscopy time, min | 15.5 (13–19) |
| Complications, n (%) | |
| Pericardial effusion | 0 (0) |
| Air embolism | 0 (0) |
| Major bleeding | 0 (0) |
| Minor bleeding | 3 (10) |
| TEE, n (%) | |
| Successful implantation | 30 (100) |
| Minimal residual flow | 3 (10) |
| Hospitalization, days | 2 (2–2) |
All data are presented as mean ± standard deviation, n (%), or median (25th–75th percentiles). PVAC indicates pulmonary vein ablation catheter; MASC, multiarray septal catheter; MAAC, multiarray ablation catheter; LAA, left atrial appendage; and TEE, transesophageal echocardiography.